IT8423799A0 - COMPOUNDS WITH ANTI-INFLAMMATION ACTIVITY - Google Patents

COMPOUNDS WITH ANTI-INFLAMMATION ACTIVITY

Info

Publication number
IT8423799A0
IT8423799A0 IT8423799A IT2379984A IT8423799A0 IT 8423799 A0 IT8423799 A0 IT 8423799A0 IT 8423799 A IT8423799 A IT 8423799A IT 2379984 A IT2379984 A IT 2379984A IT 8423799 A0 IT8423799 A0 IT 8423799A0
Authority
IT
Italy
Prior art keywords
compounds
inflammation activity
inflammation
activity
Prior art date
Application number
IT8423799A
Other languages
Italian (it)
Other versions
IT1196348B (en
Inventor
Giancarlo Sportoletti
Original Assignee
Italfarmaco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Italfarmaco Spa filed Critical Italfarmaco Spa
Publication of IT8423799A0 publication Critical patent/IT8423799A0/en
Priority to IT23799/84A priority Critical patent/IT1196348B/en
Priority to GR852834A priority patent/GR852834B/el
Priority to AU52311/86A priority patent/AU5231186A/en
Priority to JP61500163A priority patent/JPS62501703A/en
Priority to PCT/EP1985/000645 priority patent/WO1986003199A1/en
Priority to EP86900097A priority patent/EP0236329A1/en
Priority to ZA859035A priority patent/ZA859035B/en
Priority to CN198585109554A priority patent/CN85109554A/en
Priority to PT81566A priority patent/PT81566B/en
Priority to ES549359A priority patent/ES8701717A1/en
Priority to DK346486A priority patent/DK346486A/en
Priority to KR1019860700507A priority patent/KR870700608A/en
Application granted granted Critical
Publication of IT1196348B publication Critical patent/IT1196348B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56Amides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT23799/84A 1984-11-29 1984-11-29 COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY IT1196348B (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (en) 1984-11-29 1984-11-29 COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY
GR852834A GR852834B (en) 1984-11-29 1985-11-25
ZA859035A ZA859035B (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives,salts thereof,process for their preparation and pharmaceutical compositions containing them
JP61500163A JPS62501703A (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives, their salts, their preparation and pharmaceutical compositions containing them
PCT/EP1985/000645 WO1986003199A1 (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives and pharmaceutical compositions
EP86900097A EP0236329A1 (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives and pharmaceutical compositions
AU52311/86A AU5231186A (en) 1984-11-29 1985-11-26 Amino-salicylic acid derivatives salts thereof process for their preparation and pharmaceutical compositions containing them
CN198585109554A CN85109554A (en) 1984-11-29 1985-11-27 The preparation method of aminosallcylic acid derivative and salt thereof and its medicinal compositions
PT81566A PT81566B (en) 1984-11-29 1985-11-27 Process for preparing amino-salicylic acid derivatives
ES549359A ES8701717A1 (en) 1984-11-29 1985-11-28 Amino-salicylic acid derivatives and pharmaceutical compositions.
DK346486A DK346486A (en) 1984-11-29 1986-07-21 AMINOSALICYLIC ACID DERIVATIVES AND PHARMACEUTICAL AGENTS
KR1019860700507A KR870700608A (en) 1984-11-29 1986-07-28 Amino-salicylic acid derivatives and pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23799/84A IT1196348B (en) 1984-11-29 1984-11-29 COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY

Publications (2)

Publication Number Publication Date
IT8423799A0 true IT8423799A0 (en) 1984-11-29
IT1196348B IT1196348B (en) 1988-11-16

Family

ID=11210091

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23799/84A IT1196348B (en) 1984-11-29 1984-11-29 COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY

Country Status (12)

Country Link
EP (1) EP0236329A1 (en)
JP (1) JPS62501703A (en)
KR (1) KR870700608A (en)
CN (1) CN85109554A (en)
AU (1) AU5231186A (en)
DK (1) DK346486A (en)
ES (1) ES8701717A1 (en)
GR (1) GR852834B (en)
IT (1) IT1196348B (en)
PT (1) PT81566B (en)
WO (1) WO1986003199A1 (en)
ZA (1) ZA859035B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9017711D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
GB9017710D0 (en) * 1990-08-13 1990-09-26 May & Baker Ltd New compositions of matter
IT1244873B (en) * 1990-09-12 1994-09-12 Depha Team Srl DERIVATIVES OF 5-AMINOSALICYLIC ACID (5-ASA) FOR THE THERAPY OF CHRONIC INTESTINAL INFLAMMATIONS
US5366987A (en) * 1991-08-22 1994-11-22 Warner-Lambert Company Isoxazolyl-substituted alkyl amide ACAT inhibitors
FR2738150B1 (en) * 1995-09-01 1997-10-31 Synthelabo USE OF SULPHASALAZINE AND ITS METABOLITES FOR THE MANUFACTURE OF A MEDICAMENT USEFUL IN THE TREATMENT OF VENOUS INSUFFICIENCY AND VENOUS ULCERS
ATE275127T1 (en) * 2000-04-19 2004-09-15 Neurotech Co Ltd COMPOUNDS, COMPOSITIONS AND METHODS FOR PREVENTING NEURODEGENERATION IN ACUTE OR CHRONIC CENTRAL NERVOUS SYSTEM INJURIES
US6964982B2 (en) 2000-04-20 2005-11-15 Neurotech Co., Ltd. Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
EP1175906B1 (en) * 2000-07-18 2005-11-09 Dainichiseika Color & Chemicals Mfg. Co., Ltd. Blood flow improvers and thrombosis preventives or remedies comprising glucosamine
EP1936375B1 (en) 2001-01-19 2010-03-31 Apex Biotechnology Corporation Non-enzymatic disposable electrode strip comprising a surfactant for detecting uric acid; method for producing the same and its use
BR0212510A (en) 2001-09-14 2004-08-24 Methylgene Inc Histone Deacetylase Inhibitor, Compound and Composition
DK1551793T3 (en) 2002-06-19 2016-04-25 Gnt Pharma Co Ltd Tetrafluorobenzyl derivatives and pharmaceutical compositions containing these for the prevention and treatment of acute and chronic neurodegenerative diseases of the central nervous system
KR100668111B1 (en) 2005-07-28 2007-01-12 (주)에스에이치제약 New aminosalicylic acid analogs, it's pharmaceutically acceptable salts and their preparations
ES2690205T3 (en) * 2006-04-13 2018-11-19 Neurotech Pharmaceuticals Co., Ltd. Pharmaceutical composition to treat or prevent inflammatory diseases
CN100422721C (en) * 2006-05-26 2008-10-01 南京大学 Aluminium ion investigating method using glycosyl naphthol
BRPI0816560A2 (en) * 2007-10-23 2015-09-01 Inst Med Molecular Design Inc Parent-1 production inhibition method method for prevention or amelioration of a disease caused by over-production of parent-1 "
KR100852962B1 (en) 2007-11-12 2008-08-20 주식회사 뉴로테크 Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
SG192488A1 (en) 2008-07-08 2013-08-30 Catabasis Pharmaceuticals Inc Fatty acid acetylated salicylates and their uses
US9085527B2 (en) 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
KR101204108B1 (en) * 2009-02-09 2012-11-22 주식회사 지엔티파마 Medicinal use of 5-benzylaminosalicylic acid derivative or its salt
AU2010289683C1 (en) 2009-09-01 2014-10-16 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
USRE46608E1 (en) 2009-09-01 2017-11-14 Catabasis Pharmaceuticals, Inc. Fatty acid niacin conjugates and their uses
WO2013175357A2 (en) * 2012-05-23 2013-11-28 Mahesh Kandula Compositions and methods for the treatment of inflammatory bowel disease
WO2014070859A1 (en) * 2012-10-30 2014-05-08 H. Lee Moffitt Cancer Center And Research Institute, Inc. Stat3 dimerization inhibitors
KR20210107828A (en) * 2018-12-28 2021-09-01 주식회사 지엔티파마 Compositions and methods for treating neurodegenerative diseases
CN111116395B (en) * 2019-12-27 2023-04-07 湖北工业大学 Multi-iodo aromatic acid compound and application thereof in resisting adenovirus 7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4546M (en) * 1964-06-09 1966-11-02
NL7008623A (en) * 1969-06-25 1970-12-29
JPS5640710B2 (en) * 1973-01-18 1981-09-22
JPS6056130B2 (en) * 1978-03-20 1985-12-09 久光製薬株式会社 Novel salicylic acid derivatives
US4536346A (en) * 1983-05-06 1985-08-20 American Cyanamid Company Aralkanamidophenyl compounds

Also Published As

Publication number Publication date
CN85109554A (en) 1986-07-23
DK346486D0 (en) 1986-07-21
IT1196348B (en) 1988-11-16
KR870700608A (en) 1987-12-30
PT81566A (en) 1985-12-01
ES8701717A1 (en) 1986-12-01
DK346486A (en) 1986-07-21
EP0236329A1 (en) 1987-09-16
AU5231186A (en) 1986-06-18
JPS62501703A (en) 1987-07-09
ES549359A0 (en) 1986-12-01
ZA859035B (en) 1986-08-27
PT81566B (en) 1987-04-07
GR852834B (en) 1986-03-27
WO1986003199A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
IT8423799A0 (en) COMPOUNDS WITH ANTI-INFLAMMATION ACTIVITY
IT1196237B (en) HEROCICLIC COMPOUNDS WITH HERBICIDE ACTIVITY
IT1176983B (en) DIPEPTIDES WITH PHARMACOLOGICAL ACTIVITY
IT1154574B (en) COMPOUNDS 1-BONE-, AZA- AND TIA-SPIROCYCLIC WITH ANALGESIC ACTIVITY
IT1190389B (en) HEXOTEPTIDES WITH HYPOTENSIVE ACTIVITY
IT1186717B (en) BENZOIL-UREE WITH INSECTICIDE ACTIVITY
IT1187756B (en) ISOINDOLINIL-ALCHIL-PIPERAZINE WITH PHARMACEUTICAL ACTIVITY
IT1161228B (en) BENZOIL-UREE WITH INSECTICIDE ACTIVITY
IT8422150A0 (en) COMPOUNDS WITH ANTIALLERGIC ACTIVITY.
DE3565983D1 (en) N-ARYLSULFONYL-N'-TRIAZINYL- AND -PYRIMIDINYL UREAS
IT8722824A0 (en) COMPOUNDS WITH CARDIOVASCULAR ACTIVITY.
IT1161927B (en) FURANO-DERIVATIVES WITH FUNGICIDE ACTIVITY
IT1142026B (en) NEW COMPOUND WITH CEREBRAL EUMETABOLIC ACTIVITY
IT1186772B (en) COMPOUND WITH PILOSTIMULATING ACTIVITY
IT8420075A0 (en) COMPOUNDS WITH ANTIBACTERIAL ACTIVITY.
IT8419682A0 (en) COMPOUNDS WITH HYPE-LOWER ACTIVITY.
IT8419683A0 (en) COMPOUNDS WITH HYPE-LOWER ACTIVITY.
IT1173196B (en) PHARMACOLOGICALLY ACTIVE IMIDAZOPYRIDIN COMPOUNDS
KR860000031U (en) Tangbigi's push-button operation
LV5402A3 (en) Cardioprotector "Mildonats"
IT1170276B (en) COMPOUNDS WITH ANTI-INFLAMMATORY ACTIVITY
IT1176635B (en) HEROCICLIC COMPOUNDS WITH HERBICIDE ACTIVITY
IT1163092B (en) NEW COMPOUNDS WITH MUCOREGULATING ACTIVITY
IT8620979A1 (en) THYOLIC COMPOUNDS WITH MUCOLYTIC ACTIVITY
IT8321763A0 (en) COMPOUND WITH GABAERGIC ACTIVITY